At a glance
ClinicalIndex Comparison RecordN/ACompleted· 48 enrolled
Drug / intervention
CytaCoat Nasal Prong +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-blinded Randomized Clinical Pilot Trial of Nasal Prongs With Proprietary Surface Coating Aiming to Reduce Bacterial Colonization
In Brief
A clinical study evaluating CytaCoat Nasal Prong and Inspiration Healthcare Inspire nCPAP Nasal Prong for Nosocomial Infections and Pneumonia, Ventilator-Associated. Completed, enrolled 48 participants across 1 site.
Detailed Summary
The study is a first step in establishing the safety and efficacy of the CytaCoat technology when applied to a medical device such as a nasal prong and the clinical data generated will serve as a basis for continuous studies in clinically significant settings such as the neonatal care units.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSweden
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
First PostedApr 2016
Primary CompletionJun 2016
Study CompletionJul 2016
TodayJul 2026
First PostedApr 29, 2016
Enrollment StartApr 1, 2016
Primary CompletionJun 1, 2016
Study CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 10.2 years ago
Interventions
CytaCoat Nasal Prongdevice
Inspiration Healthcare Inspire nCPAP Nasal Prongdevice